Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
224 studies found for:    "methodist hospital" | Open Studies | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel
Condition: Breast Cancer
Interventions: Drug: Trastuzumab Emtansine;   Drug: Trastuzumab;   Drug: Lapatinib;   Drug: Abraxane;   Drug: Paclitaxel;   Drug: Pertuzumab
2 Recruiting Olive Oil for Breast Cancer Prevention in Women at High Risk for Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Hydroxytyrosol
3 Recruiting Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone
4 Recruiting NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer
Intervention: Drug: Everolimus
5 Recruiting North American Clinical Trials Network (NACTN) for Treatment of Spinal Cord Injury - Registry
Condition: Spinal Cord Injury
Intervention: Other: No treatment
6 Recruiting Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Conditions: Ventricular Tachycardia;   Atrial Fibrillation
Interventions: Drug: Ethanol;   Procedure: Ablation
7 Recruiting Single Dose rATG for Renal Allograft Rejection
Condition: Acute (Cellular) Renal Allograft Rejection
Intervention: Drug: rATG
8 Recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Condition: EBV-positive Nasopharyngeal Carcinoma
Interventions: Genetic: DNR.NPC-specific T cells;   Genetic: DNR.NPC-specific T cells + cyclophosphamide + fludarabine
9 Recruiting TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: TDM1;   Drug: Lapatinib;   Drug: Abraxane
10 Recruiting Reducing Radioisotope Dose: the Half-Dose CZT Study
Condition: Coronary Artery Disease
Intervention: Other: Half-dose isotope for NuclearStressTest
11 Recruiting Ciprofloxacin for Prevention of BK Infection
Condition: BK Virus Infection
Interventions: Drug: Ciprofloxacin;   Drug: placebo
12 Recruiting Development & Testing of a Decision Aid for LVAD Placement
Conditions: End-Stage Heart Failure;   Bridge-to-Transplant LVAD Placement (BTT);   Destination Therapy LVAD Placement (DT);   Refusal of LVAD Placement (Decliners);   LVAD Caregivers
Intervention: Other: LVAD Decision Aid
13 Recruiting L-NMMA Plus Docetaxel in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
Condition: Metastatic Triple Negative Breast Cancer
Interventions: Drug: L-NMMA;   Drug: Docetaxel;   Drug: Amlodipine;   Drug: Pegfilgrastim
Condition: Multiple Myeloma
Intervention: Biological: TAA-specific CTLs
15 Recruiting HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: HSV-tk +Valacyclovir in Combination with Brachytherapy
16 Not yet recruiting Multi-Dose CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Genetic: CAR T Cells;   Drug: Cyclophosphamide;   Drug: Fludarabine
17 Recruiting Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Intervention: Biological: MultiTAA-specific T cells
18 Recruiting Administration of Donor MultiTAA-Specific T Cells for ALL
Condition: Leukemia, Lymphoblastic (Acute)
Intervention: Biological: MultiTAA-specific T cells
19 Recruiting Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
Conditions: Hodgkin Disease;   Non-Hodgkin Lymphoma;   Severe Chronic Active Epstein Barr Virus;   T/NK-lymphoproliferative Disease
Interventions: Biological: MABEL CTLs;   Drug: Cyclophosphamide;   Drug: Fludarabine
20 Recruiting TAA-Specific CTLS for Solid Tumors (TACTASOM)
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Endometrial Cancer;   Gastric Cancer;   Head and Neck Cancer;   HCC;   Lung Cancer;   Melanoma;   Neuroblastoma;   Sarcoma (Osteo-, Synovial, Rhabdomyo-, Etc);   Pancreatic Cancer;   Prostate Cancer;   Renal Cell Carcinoma;   Thyroid Cancer
Intervention: Biological: TAA-Specific CTLs

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years